Sophia Genetics's BRCA Tumor MASTR Plus and SOMATIC 1 MASTR Plus
Sophia Genetics has launched two new applications, BRCA Tumor MASTR Plus kit and SOMATIC 1 MASTR Plus kit. Both next-generation sequencing kits are available on Sophia DDM, the company's genomics platform, and have been given the CE-IVD mark. BRCA Tumor MASTR Plus diagnoses breast and ovarian cancers. SOMATIC 1 MASTR Plus diagnoses colorectal cancers, pancreatic cancer, thyroid follicular tumours, melanoma, and myeloid disorders.